Halozyme Therapeutics reported $873.77M in Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 1.01M 0.44M
Alnylam Pharmaceuticals ALNY:US $ 191.59M 0.31M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 32685M 301M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 44.58M 1.03M
Baxter International BAX:US $ 6167M 79M
Cara Therapeutics CARA:US $ 0 0
Cytokinetics CYTK:US $ 137.39M 1.68M
Eli Lilly And LLY:US $ 16204.5M 390.8M
Esperion Therapeutics ESPR:US $ 271.69M 92.33M
Halozyme Therapeutics HALO:US $ 873.77M 476.54M
Immunogen IMGN:US $ 1.1M 1M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Intra Cellular Therapies ITCI:US $ 0M 0M
Intrexon XON:US $ 174.52M 2.64M
JAZZ PHA JAZZ:US $ 2101.65M 6.81M
Mannkind MNKD:US $ 4.67M 117.56M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Peregrine Pharmaceuticals PPHM:US $ 96.95M 96.95M
Rigel Pharmaceuticals RIGL:US $ 19.84M 0.03M
United Therapeutics UTHR:US $ 800M 0M
Vanda Pharmaceuticals VNDA:US $ 0M 0M